(Q34602094)

3 August 2017

Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia (English)

1 reference

3 August 2017

1 reference

0 references

Giovanni A Fava

1

1 reference

3 August 2017

Manuela Bernardi

series ordinal

2

1 reference

3 August 2017

Elena Tomba

series ordinal

3

1 reference

3 August 2017

Chiara Rafanelli

series ordinal

4

1 reference

3 August 2017

16 January 2007

1 reference

The International Journal of Neuropsychopharmacology

3 August 2017

1 reference

3 August 2017

10

1 reference

3 August 2017

835-838

1 reference

3 August 2017

6

1 reference

Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors

3 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

Benzodiazepines and anxiety sensitivity in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

The intellectual crisis of psychiatric research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

Suicidal ideation and depressive mixed states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

7 January 2021

Long-term outcome of panic disorder with agoraphobia treated by exposure.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

7 January 2021

Can long-term treatment with antidepressant drugs worsen the course of depression?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

7 January 2021

The clinical interview for depression. Development, reliability and validity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

7 January 2021

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007462

7 January 2021

10.1017/S1461145706007462

Identifiers

DOI

0 references

1 reference